Tuesday, July 23, 2019
    Latest

    Multiple Sclerosis

    Home Multiple Sclerosis
    New Study Site
    Multiple Sclerosis

    USC Third Clinical Investigative Site for Advanced Stem-Cell-Based Multiple Sclerosis-Focused Clinical...

    0
    Two Medical Scientists / Neurologists, Talking and Working on a Personal Computer in Modern Laboratory. Research Scientists Making New Discoveries in the fields of Neurophysiology, Science
    Multiple Sclerosis

    Do MS Patients Face Greater Risk of Cancer? A Haukeland University...

    0
    MS Study
    Multiple Sclerosis

    Cleveland Clinic & University of Nottingham Lead MS Trial Recruiting Relapsing...

    0
    Multiple Sclerosis

    UCI-Led Stem Cell Study Leading to Human Clinical Trials for Multiple...

    0
    Multiple Sclerosis
    Multiple Sclerosis

    Peking Union Medical College Hospital Raising MS Awareness in China

    0
    Multiple Sclerosis

    MC10 & AbbVie Form Alliance  to Using BioStamp nPoint® System in...

    0
    Multiple Sclerosis
    Multiple Sclerosis

    Celgene’s Ozanimod Reduces Gray Matter Volume Loss in MS Patients

    0
    MS
    Multiple Sclerosis

    Oregon Health & Science University Breakthrough Shows Promise in Repairing Damaged...

    0
    MS
    Multiple Sclerosis

    Cedars-Sinai-Led Research Reveals Nearly 20% of People with MS are Misdiagnosed!

    0
    Multiple Sclerosis

    Novartis Drug Wins FDA Approval Despite Challenges to its $88K Price

    0
    1234Page 1 of 4
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    159 West Broadway Suite 200
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved